Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Hepatitis C, 1999 (8)
December, 1999 (1)
- Risk factors for hepatitis C transmission in the Victorian population: a telephone survey.
Watson R, Crofts N, Mitchell C, Aitken C, Hocking J, Thompson S
Aust N Z J Public Health. 1999 Dec; 23(6):622-626
November, 1999 (1)
- The impact of diagnosis of hepatitis C virus on quality of life.
Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N
Hepatology. 1999 Nov; 30(5):1299-1301
October, 1999 (1)
- Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia.
Seow HF, Mahomed NM, Mak JW, Riddell MA, Li F, Anderson DA
J Med Virol. 1999 Oct; 59(2):164-168
August, 1999 (2)
- Serological evidence for swine hepatitis E virus infection in Australian pig herds.
Chandler JD, Riddell MA, Li F, Love RJ, Anderson DA
Vet Microbiol. 1999 Aug; 68(1-2):95-105 - ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational epitope expressed in Escherichia coli.
Anderson DA, Li F, Riddell M, Howard T, Seow HF, Torresi J, Perry G, Sumarsidi D, Shrestha SM, Shrestha IL
J Virol Methods. 1999 Aug; 81(1-2):131-142
May, 1999 (1)
- Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells.
Torresi J, Li F, Locarnini SA, Anderson DA
J Gen Virol. 1999 May; 80 ( Pt 5):1185-1188
March, 1999 (2)
- The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
Crofts N, Aitken CK, Kaldor JM
Med J Aust. 1999 Mar; 170(5):220-221 - Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study.
Rodger AJ, Thomson JA, Thompson SC, Jolley D, Mijch AM, Lanigan A, Crofts N
J Gastroenterol Hepatol. 1999 Mar; 14(3):269-273
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (0)
- Towards Eliminating HIV (0)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (0)
- Maternal, Child and Adolescent Health (0)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (0)
- Eliminate Malaria (0)
- Eliminate Tuberculosis (TB) (0)
- Finance (0)
- Healthy Ageing (0)
- Human Resources (0)
- Burnet Honorary Research Fellows (0)
- Research Support and Facilities (0)
- Harm Reduction (0)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (0)
- Education & Training (0)
- Infectious Diseases Elimination (0)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (13)
- Immune Disease and Cancer (7)
- Hepatitis B (4)
- Hepatitis C (8)
- Injecting Drug Use (3)
- Tuberculosis (TB) (1)
